Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 26, Number 5—May 2020

Epidemiology of Tick-Borne Relapsing Fever in Endemic Area, Spain

María Carmen DomínguezComments to Author , Salvador Vergara, María Carmen Gómez, and María Esther Roldán
Author affiliations: Hospital de la Merced, Osuna, Spain (M.C. Domínguez, M.C. Gómez, M.E. Roldán); Hospital del Tomillar, Seville, Spain (S. Vergara)

Main Article

Table 1

Characteristics of 98 patients with tick-borne relapsing fever, Spain*

Variable Value
Median age, y (IQR)
29 (17–46)
M 55 (56.1)
43 (43.9)
Town of residence
Osuna 40 (40.8)
Ecija 20 (20.4)
38 (38.8)
Risk activities
Farming 15 (15.3)
Hiking 10 (10.2)
3 (3.1)
Contact with rodents 13 (13.3)
Tick bite 17 (17.3)
JHR, n = 79 8 (10.1)
Median time before diagnosis, d (IQR) 3 (2–5)
Hospitalized 56 (57.1)
Median length of hospital admission, d (IQR)
5 (4–6)
Antimicrobial drug treatment
Tetracycline 79 (80.6)
Macrolides 18 (18.4)
Cephalosporin 9 (9.2)
Penicillin G
2 (2)
Duration of antimicrobial therapy, d (IQR) 10 (7–14)
*Values are no. (%) except as indicated. IQR, interquartile range; JHR, Jarisch-Herxheimer reaction.
†Except where noted.

Main Article

Page created: April 16, 2020
Page updated: April 16, 2020
Page reviewed: April 16, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.